{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:15:39Z","timestamp":1790046939266,"version":"4.0.1"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000321","name":"World Cancer Research Fund","doi-asserted-by":"publisher","award":["IIG_FULL_2021_007"],"award-info":[{"award-number":["IIG_FULL_2021_007"]}],"id":[{"id":"10.13039\/501100000321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["FPU19\/02117"],"award-info":[{"award-number":["FPU19\/02117"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013514","name":"Wereld Kanker Onderzoek Fonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013514","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PI20\/00645"],"award-info":[{"award-number":["PI20\/00645"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["FORT23\/00023"],"award-info":[{"award-number":["FORT23\/00023"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PI23\/00396"],"award-info":[{"award-number":["PI23\/00396"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CNS2023\\u2013144144"],"award-info":[{"award-number":["CNS2023\\u2013144144"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100029467","name":"Property and Environment Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100029467","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.critrevonc.2025.104950","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:31:51Z","timestamp":1757781111000},"page":"104950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Proteomics signatures of human breast cancer: A systematic review"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0743-1283","authenticated-orcid":false,"given":"Celia","family":"Garc\u00eda-Chico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Plaza-Florido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"L\u00f3pez-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Pinto-Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Maroto-Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayvan","family":"Khoramipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Sagarra-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Fiuza-Luces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Santos-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.critrevonc.2025.104950_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4331\/wjbc.v12.i5.57","article-title":"Proteomics: concepts and applications in human Medicine","volume":"12","author":"Al-Amrani","year":"2021","journal-title":"Wold J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104950_bib2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.sjbs.2020.01.020","article-title":"Proteomics approach and techniques in identification of reliable biomarkers for diseases","volume":"27","author":"Alharbi","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104950_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.736361","article-title":"The effect of local renin angiotensin system in the common types of cancer","volume":"12","author":"Almutlaq","year":"2021","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2025.104950_bib4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/15476286.2020.1822636","article-title":"Identification of spliceosome components pivotal to breast cancer survival","volume":"18","author":"An","year":"2021","journal-title":"RNA Biol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104950_bib5","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.3390\/ijms25063142","article-title":"Targeting the warburg effect in cancer: where do we stand?","volume":"25","author":"Barba","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104950_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.569377","article-title":"Proteoglycans as mediators of cancer tissue mechanics","volume":"8","author":"Barkovskaya","year":"2020","journal-title":"Front Cell Dev. Biol."},{"issue":"D1","key":"10.1016\/j.critrevonc.2025.104950_bib7","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the universal protein knowledgebase in 2023","volume":"51","author":"Bateman","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104950_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141876","article-title":"Proteomic analysis of urine to identify breast cancer biomarker candidates using a label-free LC-MS\/MS approach","volume":"10","author":"Beretov","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2025.104950_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126595","article-title":"Understanding the mechanistic pathways and clinical aspects associated with protein and gene based biomarkers in breast cancer","volume":"253","author":"Behl","year":"2023","journal-title":"Int J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104950_bib10","first-page":"1772","volume":"5","author":"Bertucci","year":"2006","journal-title":"Proteomics breast cancer Principles potential clinical applications. Mol Cell Proteomics"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104950_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/pharmaceutics13050723","article-title":"Current state of breast cancer diagnosis, treatment, and theranostics","volume":"13","author":"Bhushan","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.critrevonc.2025.104950_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/bs.ircmb.2020.05.006","article-title":"Actin regulators in cancer progression and metastases: from structure and function to cytoskeletal dynamics","volume":"356","author":"Biber","year":"2020","journal-title":"Int Rev. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12014-023-09424-x","article-title":"Mass spectrometry-based proteomics as an emerging tool in clinical laboratories","volume":"20","author":"Birhanu","year":"2023","journal-title":"Clin. Proteom."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104950_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3892\/or.2012.1849","article-title":"Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach","volume":"28","author":"B\u00f6hm","year":"2012","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s12859-019-3036-6","article-title":"Measuring rank robustness in scored protein interaction networks","volume":"20","author":"Bozhilova","year":"2019","journal-title":"BMC Bioinforma."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104950_bib16","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104950_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: from biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12885-019-5547-y","article-title":"Differential proteomic comparison of breast cancer secretome using a quantitative paired analysis workflow","volume":"19","author":"Brunoro","year":"2019","journal-title":"BMC Cancer"},{"issue":"16","key":"10.1016\/j.critrevonc.2025.104950_bib19","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/jnci\/92.16.1329","article-title":"Serum soluble vascular cell adhesion Molecule-1: role as a surrogate marker of angiogenesis","volume":"92","author":"Byrne","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2025.104950_bib20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/1471-2407-10-476","article-title":"Large-scale proteomic identification of S100 proteins in breast cancer tissues","volume":"10","author":"Cancemi","year":"2010","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104950_bib21","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1074\/mcp.M110.000398","article-title":"In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology","volume":"9","author":"Cha","year":"2010","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.critrevonc.2025.104950_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/labinvest.2014.128","article-title":"Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma","volume":"95","author":"Chen","year":"2015","journal-title":"Lab Invest"},{"key":"10.1016\/j.critrevonc.2025.104950_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.109396","article-title":"Identification of significant hub genes and pathways associated with metastatic breast cancer and tolerogenic dendritic cell via bioinformatics analysis","volume":"184","author":"Ching","year":"2025","journal-title":"Comput. Biol. Med"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104950_bib24","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.3390\/ijms24076834","article-title":"A basic review on estrogen receptor signaling pathways in breast cancer","volume":"24","author":"Clusan","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104950_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jprot.2016.07.030","article-title":"Identifying potential markers in breast cancer subtypes using plasma label-free proteomics","volume":"151","author":"Corr\u00eaa","year":"2017","journal-title":"J. Proteom."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104950_bib26","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/s41374-022-00830-7","article-title":"High-throughput proteomics: a methodological mini-review","volume":"102","author":"Cui","year":"2022","journal-title":"Lab Invest"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104950_bib27","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.7150\/jca.13141","article-title":"Cancer hallmarks, biomarkers and breast cancer molecular subtypes","volume":"7","author":"Dai","year":"2016","journal-title":"J. Cancer"},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104950_bib28","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.3390\/cancers13153918","article-title":"The role of chronic inflammation in the development of breast cancer","volume":"13","author":"Danforth","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104950_bib29","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.3390\/cancers15235565","article-title":"The role of apolipoproteins in the commonest cancers: a review","volume":"15","author":"Darwish","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/s24010037","article-title":"Biomarkers in cancer detection, diagnosis, and prognosis","volume":"24","author":"Das","year":"2024","journal-title":"Sens. (Basel)"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib31","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/s41467-020-15283-z","article-title":"Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors","volume":"11","author":"Djomehri","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.104950_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920940939","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in estrogen-receptor positive HER2 negative advanced breast cancer","volume":"12","author":"Du Rusquec","year":"2020","journal-title":"Ther. Adv. Med Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104950_bib33","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20211577","article-title":"Deregulation of ribosomal proteins in human cancers.","volume":"41","author":"El Khoury","year":"2021","journal-title":"Biosci Rep"},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104950_bib34","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1158\/0008-5472.CAN-21-4087","article-title":"Ribosome biogenesis: a central player in cancer metastasis and therapeutic resistance","volume":"82","author":"Elhamamsy","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104950_bib35","first-page":"13","article-title":"Conceptual, regulatory and strategic imperatives in the early days of EEG-Based biomarker validation for neurodevelopmental disabilities","author":"Ewen","year":"2019","journal-title":"Front Integr. Neurosci."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104950_bib36","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.21873\/invivo.12003","article-title":"Implications of low serum albumin as a prognostic factor of Long-term outcomes in patients with breast cancer","volume":"34","author":"Fujii","year":"2020","journal-title":"Vivo"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104950_bib37","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3390\/cancers11081097","article-title":"Apolipoprotein A-I (ApoA-I), immunity, inflammation and cancer","volume":"11","author":"Georgila","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2025.104950_bib38","doi-asserted-by":"crossref","first-page":"4454744","DOI":"10.1155\/2024\/4454744","article-title":"Proteomics and its current application in biomedical area: concise review","volume":"2024","author":"Gobena","year":"2024","journal-title":"ScientificWorldJournal"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104950_bib39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/mc.20395","article-title":"p53 regulates FAK expression in human tumor cells","volume":"47","author":"Golubovskaya","year":"2008","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.critrevonc.2025.104950_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jprot.2019.02.007","article-title":"Quantitative label-free mass spectrometry using contralateral and adjacent breast tissues reveal differentially expressed proteins and their predicted impacts on pathways and cellular functions in breast cancer","volume":"199","author":"Gomig","year":"2019","journal-title":"J. Proteom."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104950_bib41","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.smim.2016.10.011","article-title":"Hypercoagulation and complement: connected players in tumor development and metastases","volume":"28","author":"Guglietta","year":"2016","journal-title":"Semin Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104950_bib43","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.critrevonc.2025.104950_bib46","article-title":"Protein biomarkers for diagnosis of breast cancer","volume":"25","author":"Iweala","year":"2024","journal-title":"Sci. Afr."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104950_bib47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41392-021-00728-8","article-title":"Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy","volume":"6","author":"Kang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"43","key":"10.1016\/j.critrevonc.2025.104950_bib49","doi-asserted-by":"crossref","first-page":"69592","DOI":"10.18632\/oncotarget.11870","article-title":"EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer","volume":"7","author":"Katsyv","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104950_bib50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10549-005-9024-8","article-title":"Provasopressin expression by breast cancer cells: implications for growth and novel treatment strategies","volume":"95","author":"Keegan","year":"2006","journal-title":"Breast Cancer Res Treat."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104950_bib51","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/bjc.2017.313","article-title":"Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study","volume":"117","author":"K\u00fchn","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104950_bib52","doi-asserted-by":"crossref","first-page":"1108695","DOI":"10.3389\/fonc.2022.1108695","article-title":"Matrix metalloproteinases as therapeutic targets in breast cancer","volume":"12","author":"Kwon","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2025.104950_bib53","article-title":"Application of proteomics in cancer: recent trends and approaches for biomarkers discovery","volume":"8","author":"Kwon","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104950_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243487","article-title":"Missing value imputation in proximity extension assay-based targeted proteomics data","volume":"15","author":"Lenz","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104950_bib55","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/jcm11051250","article-title":"The role of extracellular matrix proteins in breast cancer","volume":"11","author":"Lepucki","year":"2022","journal-title":"J. Clin. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib56","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3390\/ijms24010806","article-title":"RPS24 is associated with a poor prognosis and immune infiltration in hepatocellular carcinoma","volume":"24","author":"Li","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.critrevonc.2025.104950_bib57","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.3390\/cancers13143517","article-title":"Targeting PI3K\/AKT\/mTOR signaling pathway in breast cancer","volume":"13","author":"Li","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2025.104950_bib58","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fgene.2019.00180","article-title":"Identification of Triple-Negative breast cancer genes and a novel High-Risk breast cancer prediction model development based on PPI data and support vector machines","volume":"10","author":"Li","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.critrevonc.2025.104950_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2023.100517","article-title":"Essential genes analysis reveals small ribosomal subunit protein eS28 May be a prognostic factor and potential vulnerability in osteosarcoma","volume":"44","author":"Liang","year":"2024","journal-title":"J. Bone Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","article-title":"Amino acids in cancer","volume":"52","author":"Lieu","year":"2020","journal-title":"Exp. Mol. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10549-020-05916-8","article-title":"Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancer","volume":"185","author":"Lin","year":"2021","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib62","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104950_bib63","doi-asserted-by":"crossref","first-page":"1036140","DOI":"10.3389\/fphar.2022.1036140","article-title":"Targeting ferroptosis, the achilles\u2019 heel of breast cancer: a review","volume":"13","author":"Liu","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.critrevonc.2025.104950_bib64","article-title":"Amino acid metabolism in breast cancer: pathogenic drivers and therapeutic opportunities","author":"Liu","year":"2025","journal-title":"Protein Cell pwaf011"},{"key":"10.1016\/j.critrevonc.2025.104950_bib65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fonc.2017.00014","article-title":"Label-free proteome analysis of plasma from patients with breast cancer: Stage-specific protein expression","volume":"7","author":"Lobo","year":"2017","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2025.104950_bib66","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13058-022-01562-8","article-title":"Kr\u00fcppel-like factor 7 influences translation and pathways involved in ribosomal biogenesis in breast cancer","volume":"24","author":"L\u00fcchtenborg","year":"2022","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13046-025-03279-w","article-title":"Targeting RNA splicing modulation: new perspectives for anticancer strategy?","volume":"44","author":"Lv","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104950_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000872","article-title":"Nucleotide de novo synthesis increases breast cancer stemness and metastasis via cGMP-PKG-MAPK signaling pathway","volume":"18","author":"Lv","year":"2020","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib69","doi-asserted-by":"crossref","first-page":"7680","DOI":"10.1038\/s41467-023-43485-8","article-title":"Evaluation of circulating plasma proteins in breast cancer using mendelian randomisation","volume":"14","author":"M\u00e4larstig","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib70","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.thromres.2022.01.019","article-title":"Hemostatic system activation in breast cancer: searching for new biomarkers for cancer risk prediction and outcomes","volume":"213","author":"Marchetti","year":"2022","journal-title":"Thromb. Res."},{"issue":"29","key":"10.1016\/j.critrevonc.2025.104950_bib71","doi-asserted-by":"crossref","first-page":"48471","DOI":"10.18632\/oncotarget.17265","article-title":"Cell matrix adhesions in cancer: the proteins that form the glue","volume":"8","author":"Maziveyi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2025.104950_bib72","doi-asserted-by":"crossref","first-page":"1100938","DOI":"10.3389\/fcell.2023.1100938","article-title":"Actin cytoskeleton depolymerization increases matrix metalloproteinase gene expression in breast cancer cells by promoting translocation of cysteine-rich protein 2 to the nucleus","volume":"11","author":"Mgrditchian","year":"2023","journal-title":"Front Cell Dev. Biol."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104950_bib73","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.3390\/cancers15194689","article-title":"Estrogen receptor signaling in breast cancer","volume":"15","author":"Miziak","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2025.104950_bib74","unstructured":"Moola S., Munn Z., Tufanaru C., Aromataris E., Sears K., Sfetcu R., et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. Joanna Briggs Institute Reviewer\u2019s Manual. Adelaide: The Joanna Briggs Institute; 2017 [cited 2025 Jul 17]. Available from: https:\/\/reviewersmanual.joannabriggs.org\/."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104950_bib75","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/15384101.2018.1444305","article-title":"Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK\/STAT3 signaling pathway in breast cancer","volume":"17","author":"Mu","year":"2018","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104950_bib76","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","article-title":"Nucleotide metabolism: a pan-cancer metabolic dependency","volume":"23","author":"Mullen","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104950_bib77","first-page":"4006","article-title":"Proteomics and its applications in breast cancer","volume":"11","author":"Neagu","year":"2021","journal-title":"Am. J. Cancer Res"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104950_bib78","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/bjc.2017.118","article-title":"One-carbon metabolism in cancer","volume":"116","author":"Newman","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104950_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.618839","article-title":"IL-1\u03b2 promotes vasculogenic mimicry of breast cancer cells through p38\/MAPK and PI3K\/Akt signaling pathways","volume":"11","author":"Nisar","year":"2021","journal-title":"Front Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104950_bib80","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1629780","article-title":"Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome","volume":"8","author":"Noblejas-L\u00f3pez","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.critrevonc.2025.104950_bib81","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2147\/OTT.S425723","article-title":"Cancer and the vasopressin gene: radioimmunoassay values and commentary on copeptin as a plasma marker","volume":"16","author":"North","year":"2023","journal-title":"Onco Targets Ther."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104950_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03728","article-title":"Comparing blood versus tissue-based biomarkers expression in breast cancer patients","volume":"6","author":"Oloomi","year":"2020","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcla.20492","article-title":"Search for breast cancer biomarkers in fractionated serum samples by protein profiling with SELDI-TOF MS","volume":"26","author":"Opstal-van Winden","year":"2014","journal-title":"J. Clin. Lab Anal."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104950_bib84","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.tem.2023.08.001","article-title":"The exercise IL-6 enigma in cancer","volume":"34","author":"Orange","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"issue":"16","key":"10.1016\/j.critrevonc.2025.104950_bib85","doi-asserted-by":"crossref","first-page":"12690","DOI":"10.3390\/ijms241612690","article-title":"Omics technologies improving breast cancer research and diagnostics","volume":"24","author":"Orsini","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104950_bib86","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104950_bib87","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1758834014530023","article-title":"The PI3K\/AKT\/mTOR pathway in breast cancer: targets, trials and biomarkers","volume":"6","author":"Paplomata","year":"2014","journal-title":"Ther. Adv. Med Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib88","doi-asserted-by":"crossref","first-page":"13246","DOI":"10.1038\/s41598-024-63976-y","article-title":"RPS24 alternative splicing is a marker of cancer progression and epithelial-mesenchymal transition","volume":"14","author":"Park","year":"2024","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.critrevonc.2025.104950_bib89","doi-asserted-by":"crossref","first-page":"8598","DOI":"10.1158\/0008-5472.CAN-10-1676","article-title":"Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users","volume":"70","author":"Pitteri","year":"2010","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib90","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1038\/s41598-023-35764-7","article-title":"Increased plasma lipids in triple-negative breast cancer and impairment in HDL functionality in advanced stages of tumors","volume":"13","author":"Sawada","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104950_bib91","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ijbiomac.2021.06.140","article-title":"Serum albumin levels and inflammation","volume":"184","author":"Sheinenzon","year":"2021","journal-title":"Int J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100703","article-title":"Proteomic analysis revealed the potential role of MAGE-D2 in the therapeutic targeting of Triple-Negative breast cancer","volume":"23","author":"Shi","year":"2024","journal-title":"Mol. Cell Proteom."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104950_bib93","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3390\/cancers13112512","article-title":"Cancers proteomics, personalized Medicine and cancer","volume":"13","author":"Su","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104950_bib94","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s12276-022-00765-5","article-title":"Functional and pathologic association of aminoacyl-tRNA synthetases with cancer","volume":"54","author":"Sung","year":"2022","journal-title":"Exp. Mol. Med"},{"issue":"D1","key":"10.1016\/j.critrevonc.2025.104950_bib95","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104950_bib96","doi-asserted-by":"crossref","first-page":"E341","DOI":"10.1016\/j.clbc.2024.12.008","article-title":"Mutations in Necroptosis-Related genes reported in breast cancer: a cosmic and uniport Database-Based study","volume":"25","author":"Thakur","year":"2024","journal-title":"Clin. Breast Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib97","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41523-023-00598-z","article-title":"PI3K\/AKT signaling activates HIF1\u03b1 to modulate the biological effects of invasive breast cancer with microcalcification","volume":"9","author":"Tian","year":"2023","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib98","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12014-022-09362-0","article-title":"Circulating proteins as predictive and prognostic biomarkers in breast cancer","volume":"19","author":"Veyssi\u00e8re","year":"2022","journal-title":"Clin. Proteom."},{"key":"10.1016\/j.critrevonc.2025.104950_bib99","article-title":"Metabolism of amino acids in cancer","volume":"8","author":"Wei","year":"2021","journal-title":"Front Cell Dev."},{"key":"10.1016\/j.critrevonc.2025.104950_bib100","unstructured":"Wells, G., Shea, B., O\u2019Connell, D., Peterson, J., Welch, V., Losos, M., Tugwell, P., 2000. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104950_bib101","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s40001-023-01364-4","article-title":"Visualization of breast cancer-related protein synthesis from the perspective of bibliometric analysis","volume":"28","author":"Xu","year":"2023","journal-title":"Eur. J. Med Res"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104950_bib102","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1673-8527(08)60108-3","article-title":"One-carbon metabolism and breast cancer: an epidemiological perspective","volume":"36","author":"Xu","year":"2009","journal-title":"J. Genet Genom."},{"key":"10.1016\/j.critrevonc.2025.104950_bib103","doi-asserted-by":"crossref","first-page":"1127446","DOI":"10.3389\/fonc.2023.1127446","article-title":"Comprehensive proteome, phosphoproteome and kinome characterization of luminal a breast cancer","volume":"13","author":"Yang","year":"2023","journal-title":"Front Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104950_bib104","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc.2016.81","article-title":"Serine and one-carbon metabolism in cancer","volume":"16","author":"Yang","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104950_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141334","article-title":"Ribosomal proteins RPS11 and RPS20, two stress-response markers of glioblastoma stem cells, are novel predictors of poor prognosis in glioblastoma patients","volume":"10","author":"Yong","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104950_bib106","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015573","article-title":"Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non- invasive detection of breast cancer","volume":"5","author":"Zhang","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104950_bib107","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3390\/cancers16030678","article-title":"Macrophages promote subtype conversion and endocrine resistance in breast cancer","volume":"16","author":"Zhang","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2025.104950_bib108","doi-asserted-by":"crossref","first-page":"1040311","DOI":"10.3389\/fcell.2022.1040311","article-title":"Functional and clinical characteristics of focal adhesion kinases in cancer progression","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2025.104950_bib109","doi-asserted-by":"crossref","first-page":"1370800","DOI":"10.3389\/fimmu.2024.1370800","article-title":"Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment","volume":"15","author":"Zhi","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2025.104950_bib110","doi-asserted-by":"crossref","first-page":"1176647","DOI":"10.3389\/fimmu.2023.1176647","article-title":"Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Immunol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825003385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825003385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:24:40Z","timestamp":1773116680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825003385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":110,"alternative-id":["S1040842825003385"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104950","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomics signatures of human breast cancer: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104950"}}